%0 Journal Article %A Bertram Pitt %A Sanjay Rajagopalan %T Aldosterone receptor antagonists for heart failure: Current status, future indications %D 2006 %J Cleveland Clinic Journal of Medicine %P 257-268 %V 73 %N 3 %X Many patients with heart failure should receive an aldosterone receptor antagonist, ie, either spironolactone (Aldactone) or the newer agent eplerenone (Inspra)—in addition to an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) or both, and a beta-blocker. We review the evidence and indications. %U https://www.ccjm.org/content/ccjom/73/3/257.full.pdf